Impact of Different Delivery Modalities on Maternal and Neonatal Outcomes During Prolonged Deceleration in the Second Stage of Labor: A Retrospective Study Authors: Wen Qian Jian, Feng Yang, Jun Jian, Mei Ping He, Chun Lan Yuan, Jian Chun Huang, Qing Fang Wei, Kai Sun Zhao Published: 2025 ABSTRACT ObjectiveTo investigate the effects of three delivery methods—vacuum extraction, forceps-assisted delivery, and cesarean section—on maternal and neonatal outcomes during prolonged deceleration (PD) in the second stage of labor, providing evidence-based support for clinical decision-making.MethodsThis retrospective cohort study analyzed 114 singleton, term pregnancies with vertex presentation experiencing PD in the second stage of labor between January 2022 and December 2024. Participants were categorized by delivery method: vacuum extraction (n=62), forceps delivery (n=30), and cesarean section (n=22). Primary outcomes included maternal morbidity indicators (eg, blood loss, hospital stay) and neonatal outcomes (eg, umbilical artery pH, NICU admission).ResultsThe cesarean section group had a higher fetal station, a longer deceleration-to-delivery interval, and significantly increased maternal morbidity, including longer postpartum hospital stay, higher costs, extended antibiotic use and catheterization, and greater blood loss compared to instrumental delivery groups (all P < 0.05). The forceps group had a higher incidence of wound erythema than the cesarean group (P < 0.05). Critically, neonatal outcomes were comparable across all three groups (P > 0.05).ConclusionDuring PD in the second stage of labor, both operative vaginal delivery and cesarean section present a trade-off between maternal morbidity and procedural expediency. The choice of delivery method should be individualized, based on a rapid assessment of fetal station, labor progress, and operator expertise, as neonatal short-term outcomes were similar regardless of the mode of delivery. Introduction Against the backdrop of declining global fertility rates,1 improving the childbirth experience holds significant strategic importance for enhancing fertility intentions and addressing negative population growth. With the widespread adoption of electronic fetal monitoring (EFM), clinicians’ ability to identify fetal heart rate deceleration patterns has markedly improved. Prolonged deceleration (PD) is defined as a decrease in fetal heart rate of 15 beats per minute (bpm) or more below the baseline, lasting for at least 2 minutes but less than 10 minutes; if it persists for 10 minutes or longer, it is classified as a baseline change.2–4 The primary mechanisms involve fetal myocardial hypoxia and vagal reflexes. The clinical management of PD remains contentious. Some experts regard it as a sign of acute fetal distress, advocating for active intervention and expedited delivery.4 Conversely, others suggest that not all PD episodes require immediate cesarean section, especially when caused by reversible factors such as uterine tachysystole or maternal supine hypotension.2,5 Moreover, increasing duration or depth of deceleration significantly raises the risk of neonatal acidosis and adverse outcomes.6 In the first stage of labor, there is a general clinical consensus to consider cesarean delivery when persistent decelerations indicate acute fetal hypoxia, aiming to optimize perinatal outcomes.7 In contrast, decision-making in the second stage is more complex, involving a choice between proceeding with an operative vaginal delivery (vacuum or forceps) or performing a full-dilatation cesarean section, each with distinct maternal and neonatal risks. The American College of Obstetricians and Gynecologists (ACOG) advises against the combined use of vacuum extractor and forceps in an operative vaginal delivery.8 Selecting the appropriate delivery mode is crucial for optimizing both maternal and neonatal outcomes.9 Despite its clinical significance, comparative evidence on the outcomes of these different approaches specifically during PD in the second stage is scarce. This study aimed to compare the impact of vacuum extraction, forceps delivery, and cesarean section on maternal and neonatal outcomes following PD in the second stage of labor. Our goal is to provide evidence-based guidance to assist obstetric teams in making timely and rational decisions, ultimately enhancing maternal and neonatal safety. Materials and Methods Study Population and Design This single-center retrospective observational study was conducted at Nanning Second People’s Hospital. We included singleton, vertex-presenting pregnancies at ≥34 weeks gestation who experienced PD in the second stage of labor between January 2022 and December 2024. PD was defined per standard criteria:2–4 a fetal heart rate deceleration of ≥15 bpm below baseline, lasting ≥2 minutes but <10 minutes, occurring after full cervical dilation. Inclusion and Exclusion Criteria Inclusion criteria were: (1) PD in the second stage; (2) singleton, vertex presentation; (3) gestational age ≥34 weeks; (4) complete clinical data. Exclusion criteria were categorized as: (1) Fetal factors: non-vertex presentation, known congenital anomalies, multiple gestation. (2) Maternal factors: significant comorbidities (eg, severe preeclampsia, cardiac disease), pelvic deformities. (3) Delivery outcome: spontaneous vaginal delivery after PD. After screening, 114 patients were enrolled and stratified by delivery method: vacuum extraction (n=62, KIWI system), forceps delivery (n=30, Simpson forceps), and cesarean section (n=22). All operative vaginal deliveries were conducted at fetal station ≥+2, whereas the cesarean group predominantly had station ≤+2. Clinical Management and Data Collection The decision to intervene and the choice of delivery method were at the discretion of the attending obstetrician, based on a comprehensive assessment including fetal station, position, estimated fetal weight, maternal pelvis, and clinical urgency. Standard intrauterine resuscitation (maternal repositioning, oxygen, intravenous fluids) was routinely attempted prior to intervention. The case selection process involved retrieving all cases containing the keyword “prolonged deceleration” from the electronic medical record system. Cases where PD did not occur in the second stage, as well as five cases where PD occurred in the second stage but culminated in spontaneous vaginal delivery, were excluded. Ultimately, enrolled patients were divided into three groups based on delivery method: a vacuum extraction group (n=62, using KIWI vacuum system), a forceps delivery group (n=30, using Simpson forceps), and a cesarean section group (n=22). All women undergoing operative vaginal delivery had fetal station ≥+2; in contrast, the cesarean group had fetal station ≤+2. (Fetal station was defined as follows: the leading point of the fetal skull at the level of the ischial spines is “0”; one centimeter below the spines is “+1”, and so forth). This study was approved by the Ethics Committee of Nanning Second People’s Hospital. Given its retrospective nature and anonymized data, the committee waived the requirement for informed consent in accordance with the Declaration of Helsinki and relevant regulations. Data Were Extracted from Electronic Medical Records and Included Baseline characteristics: maternal age, BMI, parity, hemoglobin. Fetal monitoring parameters: deceleration-to-delivery interval, number/duration/depth of decelerations. Neonatal outcomes: birth weight, umbilical artery blood gas (pH, lactate), NICU admission. (Umbilical cord blood was routinely sampled immediately after delivery for gas analysis). (pH < 7.20 is a critical threshold for neonatal asphyxia diagnosis,10 indicating neonatal acidosis.11) Maternal outcomes: estimated blood loss (measured via gravimetric + volumetric suction), postpartum hospital stay, hospitalization costs, antibiotic/catheter duration, and complications (eg, wound erythema, fever). Related Work Disclosure: This study utilizes a cohort that overlaps with that of a related study by our group focusing on risk factors for umbilical acidosis during prolonged deceleration. The two manuscripts address distinct, sequential research questions (risk factors vs. management outcomes) and are reported separately to maintain analytical clarity.12 Statistical Analysis Statistical analyses were performed using SPSS version 29.0. Categorical data are expressed as numbers (percentages) and compared with the chi-square (χ2) test; Fisher’s exact test was used when expected cell counts were less than 5. Continuous data were assessed for normality. For normally distributed variables, results are presented as mean ± standard deviation (SD), and group comparisons were conducted using one-way analysis of variance (ANOVA). For non-normally distributed variables, results are expressed as median (interquartile range, IQR), and comparisons among groups used the Kruskal–Wallis H-test. Post-hoc pairwise comparisons used the Bonferroni correction. A P-value < 0.05 was considered statistically significant for all analyses. Given the sample size limitations, findings were interpreted with emphasis on clinical significance. Given the sample size limitations, findings were interpreted with emphasis on clinical significance. In the results presentation, exact P-values are reported where appropriate, and P < 0.001 is used to denote high statistical significance beyond the preset threshold. Results Comparison of Baseline Characteristics No statistically significant differences were observed among the three groups regarding maternal age, pre-pregnancy BMI, pre-delivery BMI, gestational weight gain, gravidity, or parity (all P > 0.05), (Table 1).Table 1Comparison of General Data of the Three GroupsGroupF/HP95% CIAge (years)Vacuum-assisted delivery (62 cases)29.31 ± 5.270.22827.97–30.64Forceps Delivery (30 cases)28.83 ± 5.0926.93–30.74Cesarean Section (22 cases)28.45 ± 6.0125.70–31.12Pre-pregnancy BMIVacuum-assisted delivery (62 cases)21.45 ± 3.020.53820.68–22.22Forceps Delivery (30 cases)20.91 ± 3.2619.69–22.13Cesarean Section (22 cases)21.81 ± 3.5820.22–23.29Prepartum BMIVacuum-assisted delivery (62 cases)26.17 ± 3.010.53825.41–26.93Forceps Delivery (30 cases)25.39 ± 3.4524.10–26.67Cesarean Section (22 cases)26.69 ± 4.0224.91–28.48Weight Gain (kg)Vacuum-assisted delivery (62 cases)11.43 ± 3.250.16310.60–12.25Forceps Delivery (30 cases)11.01 ± 3.139.84–12.18Cesarean Section (22 cases)11.27 ± 3.589.68–12.86ParityVacuum-assisted delivery (62 cases)1 (1, 3)0.289Forceps Delivery (30 cases)1 (1, 2)Cesarean Section (22 cases)1 (1, 2.25)Number of DeliveriesVacuum-assisted delivery (62 cases)1 (1, 2)2.292Forceps Delivery (30 cases)1 (1, 1)Cesarean Section (22 cases)1 (1, 1)Notes: For non-normally distributed variables, data are presented as median (interquartile range). Confidence intervals for the median, which require resampling methods for calculation, are not reported due to their interpretive complexity and minimal impact on the primary conclusions.Abbreviation: BMI, Body Mass Index. Table 1Comparison of General Data of the Three GroupsGroupF/HP95% CIAge (years)Vacuum-assisted delivery (62 cases)29.31 ± 5.270.22827.97–30.64Forceps Delivery (30 cases)28.83 ± 5.0926.93–30.74Cesarean Section (22 cases)28.45 ± 6.0125.70–31.12Pre-pregnancy BMIVacuum-assisted delivery (62 cases)21.45 ± 3.020.53820.68–22.22Forceps Delivery (30 cases)20.91 ± 3.2619.69–22.13Cesarean Section (22 cases)21.81 ± 3.5820.22–23.29Prepartum BMIVacuum-assisted delivery (62 cases)26.17 ± 3.010.53825.41–26.93Forceps Delivery (30 cases)25.39 ± 3.4524.10–26.67Cesarean Section (22 cases)26.69 ± 4.0224.91–28.48Weight Gain (kg)Vacuum-assisted delivery (62 cases)11.43 ± 3.250.16310.60–12.25Forceps Delivery (30 cases)11.01 ± 3.139.84–12.18Cesarean Section (22 cases)11.27 ± 3.589.68–12.86ParityVacuum-assisted delivery (62 cases)1 (1, 3)0.289Forceps Delivery (30 cases)1 (1, 2)Cesarean Section (22 cases)1 (1, 2.25)Number of DeliveriesVacuum-assisted delivery (62 cases)1 (1, 2)2.292Forceps Delivery (30 cases)1 (1, 1)Cesarean Section (22 cases)1 (1, 1)Notes: For non-normally distributed variables, data are presented as median (interquartile range). Confidence intervals for the median, which require resampling methods for calculation, are not reported due to their interpretive complexity and minimal impact on the primary conclusions.Abbreviation: BMI, Body Mass Index. Comparison of General Data of the Three Groups Notes: For non-normally distributed variables, data are presented as median (interquartile range). Confidence intervals for the median, which require resampling methods for calculation, are not reported due to their interpretive complexity and minimal impact on the primary conclusions. Abbreviation: BMI, Body Mass Index. Comparison of Fetal Monitoring Indicators and Pregnancy Charact Key differences were observed in parameters influencing delivery method selection and timing (Table 2). The deceleration-to-delivery interval was significantly longer in the cesarean section group compared to both the vacuum and forceps groups (P < 0.05). Conversely, the number of deceleration episodes was lower in the cesarean group than in the vacuum group (P < 0.05). Fetal station was significantly higher (less descent) in the cesarean group than in both operative vaginal delivery groups (P < 0.001). Pre-delivery hemoglobin was lower in the vacuum group than in the forceps group (P < 0.05). No significant differences were found in other fetal monitoring parameters or pregnancy complication rates.Table 2Comparison of Fetal Monitoring Indicators and Pregnancy ConditionsGroupH/χ2P95% CIDuration from start of deceleration to fetal delivery (min)Vacuum-assisted delivery (62 cases)20 (15, 25.25)a13.0750.001–Forceps Delivery (30 cases)19.5 (15, 25.5)a–Cesarean Section (22 cases)39.5 (18.75, 71.5)b–Duration of single deceleration (min)Vacuum–assisted delivery (62 cases)9 (6, 12.25)0.8240.662–Forceps Delivery (30 cases)8.5 (6, 11.25)–Cesarean Section (22 cases)7 (5, 10.25)–Cumulative deceleration time (min)Vacuum–assisted delivery (62 cases)11 (9, 14)2.2070.332–Forceps Delivery (30 cases)10.5 (7.75, 16.25)–Cesarean Section (22 cases)9.5 (5.75, 14)–Number of decelerationsVacuum–assisted delivery (62 cases)2 (1, 2)a6.4850.039–Forceps Delivery (30 cases)2 (1, 2)a,b–Cesarean Section (22 cases)1 (1, 2)b–Degree of fetal heart rate decline (bpm)Vacuum-assisted delivery (62 cases)60 (47.5, 70)0.1100.947–Forceps Delivery (30 cases)60 (40, 80)–Cesarean Section (22 cases)55 (50, 60)–Baseline variability (moderate)Vacuum-assisted delivery (62 cases)41 (66.13%)2.0460.53954.01% - 78.25%Forceps Delivery (30 cases)22 (73.33%)56.54% - 90.13%Cesarean Section (22 cases)18 (81.82%)64.32% - 99.32%Non-reassuring accelerationsVacuum-assisted delivery (62 cases)28 (45.16%)0.6630.71832.42% - 57.9%Forceps Delivery (30 cases)11 (36.67%)18.36% - 54.97%Cesarean Section (22 cases)10 (45.45%) 22.86% - 68.05%Pre-delivery HB (g/L)Vacuum-assisted delivery (62 cases)121 (106.75, 125.25)a8.0960.017—Forceps Delivery (30 cases)125 (119.75, 128.25)b—Cesarean Section (22 cases)128.5 (111.75, 132.25)a,b—Pregnancy complicationsVacuum–assisted delivery (62 cases)12 (19.35%)5.7070.0589.24%–29.47%Forceps Delivery (30 cases)8 (26.67%)9.87%–43.46%Cesarean Section (22 cases)10 (45.45%)22.86%–68.05%Fetal stationVacuum–assisted delivery (62 cases)3 (2,3)a56.870.001–Forceps Delivery (30 cases)3 (2,3)a–Cesarean Section (22 cases)1 (0,1)b–Notes: Post-hoc pairwise comparisons were performed using Bonferroni correction. Within the same parameter, different letters, a,bIndicate statistically significant differences between groups (P < 0.05), while parameters without letter annotations indicate no significant differences among groups. For variables that are not normally distributed, we describe their central tendency and dispersion using the median and interquartile range (IQR). The calculation of confidence intervals for the median requires resampling methods, the interpretation of which is relatively complex and does not typically alter the main conclusions; therefore, they were not provided.Abbreviation: HB: Hemoglobin concentration. Table 2Comparison of Fetal Monitoring Indicators and Pregnancy ConditionsGroupH/χ2P95% CIDuration from start of deceleration to fetal delivery (min)Vacuum-assisted delivery (62 cases)20 (15, 25.25)a13.0750.001–Forceps Delivery (30 cases)19.5 (15, 25.5)a–Cesarean Section (22 cases)39.5 (18.75, 71.5)b–Duration of single deceleration (min)Vacuum–assisted delivery (62 cases)9 (6, 12.25)0.8240.662–Forceps Delivery (30 cases)8.5 (6, 11.25)–Cesarean Section (22 cases)7 (5, 10.25)–Cumulative deceleration time (min)Vacuum–assisted delivery (62 cases)11 (9, 14)2.2070.332–Forceps Delivery (30 cases)10.5 (7.75, 16.25)–Cesarean Section (22 cases)9.5 (5.75, 14)–Number of decelerationsVacuum–assisted delivery (62 cases)2 (1, 2)a6.4850.039–Forceps Delivery (30 cases)2 (1, 2)a,b–Cesarean Section (22 cases)1 (1, 2)b–Degree of fetal heart rate decline (bpm)Vacuum-assisted delivery (62 cases)60 (47.5, 70)0.1100.947–Forceps Delivery (30 cases)60 (40, 80)–Cesarean Section (22 cases)55 (50, 60)–Baseline variability (moderate)Vacuum-assisted delivery (62 cases)41 (66.13%)2.0460.53954.01% - 78.25%Forceps Delivery (30 cases)22 (73.33%)56.54% - 90.13%Cesarean Section (22 cases)18 (81.82%)64.32% - 99.32%Non-reassuring accelerationsVacuum-assisted delivery (62 cases)28 (45.16%)0.6630.71832.42% - 57.9%Forceps Delivery (30 cases)11 (36.67%)18.36% - 54.97%Cesarean Section (22 cases)10 (45.45%) 22.86% - 68.05%Pre-delivery HB (g/L)Vacuum-assisted delivery (62 cases)121 (106.75, 125.25)a8.0960.017—Forceps Delivery (30 cases)125 (119.75, 128.25)b—Cesarean Section (22 cases)128.5 (111.75, 132.25)a,b—Pregnancy complicationsVacuum–assisted delivery (62 cases)12 (19.35%)5.7070.0589.24%–29.47%Forceps Delivery (30 cases)8 (26.67%)9.87%–43.46%Cesarean Section (22 cases)10 (45.45%)22.86%–68.05%Fetal stationVacuum–assisted delivery (62 cases)3 (2,3)a56.870.001–Forceps Delivery (30 cases)3 (2,3)a–Cesarean Section (22 cases)1 (0,1)b–Notes: Post-hoc pairwise comparisons were performed using Bonferroni correction. Within the same parameter, different letters, a,bIndicate statistically significant differences between groups (P < 0.05), while parameters without letter annotations indicate no significant differences among groups. For variables that are not normally distributed, we describe their central tendency and dispersion using the median and interquartile range (IQR). The calculation of confidence intervals for the median requires resampling methods, the interpretation of which is relatively complex and does not typically alter the main conclusions; therefore, they were not provided.Abbreviation: HB: Hemoglobin concentration. Comparison of Fetal Monitoring Indicators and Pregnancy Conditions Notes: Post-hoc pairwise comparisons were performed using Bonferroni correction. Within the same parameter, different letters, a,bIndicate statistically significant differences between groups (P < 0.05), while parameters without letter annotations indicate no significant differences among groups. For variables that are not normally distributed, we describe their central tendency and dispersion using the median and interquartile range (IQR). The calculation of confidence intervals for the median requires resampling methods, the interpretation of which is relatively complex and does not typically alter the main conclusions; therefore, they were not provided. Abbreviation: HB: Hemoglobin concentration. Neonatal Outcomes Most importantly, no statistically significant differences were observed among the three groups for any neonatal outcome measure, including birth weight, gestational age, umbilical artery pH <7.20, lactate levels, rates of neonatal asphyxia, or NICU admission (all P > 0.05, Table 3).Table 3Comparison of Neonatal OutcomesGroupH/χ2P95% CIBirth weight (kg)Vacuum-assisted delivery (62 cases)3.09 ± 0.321.5090.4702.96–3.13Forceps Delivery (30 cases)3.06 ± 0.352.96–3.23Cesarean Section (22 cases)2.88 ± 0.402.81–3.13Gestational age at delivery (days)Vacuum-assisted delivery (62 cases)276.0 ± 7.11.5860.453271.5–276.1Forceps Delivery (30 cases)273.5 ± 6.8270.3–275.1Cesarean Section (22 cases)273.5 ± 8.5270.9–278.9Preterm birthVacuum-assisted delivery (62 cases)2 (3.2%)4.210.1220.4% - 11.2%Forceps Delivery (30 cases)1 (3.3%)0.1% - 17.2%Cesarean Section (22 cases)3 (13.6%)2.9% - 34.9%Amniotic fluid characteristics (cloudy)Vacuum-assisted delivery (62 cases)17 (27.42%)4.3920.11116.0%–38.84%Forceps Delivery (30 cases)3 (10.0%)1.39%–21.39%Cesarean Section (22 cases)7 (31.82%)10.68%–52.96%pH valueVacuum-assisted delivery (62 cases)7.18 ± 0.094.3590.113—Forceps Delivery (30 cases)7.18 ± 0.10—Cesarean Section (22 cases)7.23 ± 0.08—Low pH value (<7.20)Vacuum-assisted delivery (62 cases)36 (58.06%)4.5210.10445.43%–70.70%Forceps Delivery (30 cases)16 (53.33%)34.39%–72.28%Cesarean Section (22 cases)7 (31.82%)10.68%–52.96%Lac (mmol/L)Vacuum-assisted delivery (62 cases)5.95 (4.60, 7.55)5.1890.075—Forceps Delivery (30 cases)6.00 (4.00, 7.45)—Cesarean Section (22 cases)4.60 (3.40, 6.65)—Neonatal asphyxiaVacuum-assisted delivery (62 cases)8 (12.9%)1.2160.6555.7% - 23.9%Forceps Delivery (30 cases)3 (10.0%)2.1% - 26.5%Cesarean Section (22 cases)1 (4.5%)0.1% - 22.8%Transfer to NICUVacuum-assisted delivery (62 cases)19 (30.6%)2.5720.26719.6% - 43.7%Forceps Delivery (30 cases)7 (23.3%)9.9% - 42.3%Cesarean Section (22 cases)3 (13.6%)2.9% - 34.9%Notes: For variables that are not normally distributed, we describe their central tendency and dispersion using the median and interquartile range (IQR). The calculation of confidence intervals for the median requires resampling methods, the interpretation of which is relatively complex and does not typically alter the main conclusions; therefore, they were not provided. Table 3Comparison of Neonatal OutcomesGroupH/χ2P95% CIBirth weight (kg)Vacuum-assisted delivery (62 cases)3.09 ± 0.321.5090.4702.96–3.13Forceps Delivery (30 cases)3.06 ± 0.352.96–3.23Cesarean Section (22 cases)2.88 ± 0.402.81–3.13Gestational age at delivery (days)Vacuum-assisted delivery (62 cases)276.0 ± 7.11.5860.453271.5–276.1Forceps Delivery (30 cases)273.5 ± 6.8270.3–275.1Cesarean Section (22 cases)273.5 ± 8.5270.9–278.9Preterm birthVacuum-assisted delivery (62 cases)2 (3.2%)4.210.1220.4% - 11.2%Forceps Delivery (30 cases)1 (3.3%)0.1% - 17.2%Cesarean Section (22 cases)3 (13.6%)2.9% - 34.9%Amniotic fluid characteristics (cloudy)Vacuum-assisted delivery (62 cases)17 (27.42%)4.3920.11116.0%–38.84%Forceps Delivery (30 cases)3 (10.0%)1.39%–21.39%Cesarean Section (22 cases)7 (31.82%)10.68%–52.96%pH valueVacuum-assisted delivery (62 cases)7.18 ± 0.094.3590.113—Forceps Delivery (30 cases)7.18 ± 0.10—Cesarean Section (22 cases)7.23 ± 0.08—Low pH value (<7.20)Vacuum-assisted delivery (62 cases)36 (58.06%)4.5210.10445.43%–70.70%Forceps Delivery (30 cases)16 (53.33%)34.39%–72.28%Cesarean Section (22 cases)7 (31.82%)10.68%–52.96%Lac (mmol/L)Vacuum-assisted delivery (62 cases)5.95 (4.60, 7.55)5.1890.075—Forceps Delivery (30 cases)6.00 (4.00, 7.45)—Cesarean Section (22 cases)4.60 (3.40, 6.65)—Neonatal asphyxiaVacuum-assisted delivery (62 cases)8 (12.9%)1.2160.6555.7% - 23.9%Forceps Delivery (30 cases)3 (10.0%)2.1% - 26.5%Cesarean Section (22 cases)1 (4.5%)0.1% - 22.8%Transfer to NICUVacuum-assisted delivery (62 cases)19 (30.6%)2.5720.26719.6% - 43.7%Forceps Delivery (30 cases)7 (23.3%)9.9% - 42.3%Cesarean Section (22 cases)3 (13.6%)2.9% - 34.9%Notes: For variables that are not normally distributed, we describe their central tendency and dispersion using the median and interquartile range (IQR). The calculation of confidence intervals for the median requires resampling methods, the interpretation of which is relatively complex and does not typically alter the main conclusions; therefore, they were not provided. Comparison of Neonatal Outcomes Notes: For variables that are not normally distributed, we describe their central tendency and dispersion using the median and interquartile range (IQR). The calculation of confidence intervals for the median requires resampling methods, the interpretation of which is relatively complex and does not typically alter the main conclusions; therefore, they were not provided. Maternal Outcomes Cesarean section was associated with significantly increased maternal morbidity across multiple domains (Table 4). The cesarean group had a longer postpartum hospital stay, higher hospitalization costs, longer durations of antibiotic use and urinary catheterization, and greater estimated blood loss compared to both operative vaginal delivery groups (all P < 0.001). The incidence of wound erythema was higher in the forceps group than in the cesarean group (P < 0.05). No significant differences were found in rates of urinary retention, postpartum fever, or postpartum hemorrhage (as defined by blood loss ≥1000mL) among the groups.Table 4Comparison of Maternal OutcomesGroupH/χ2P95% CIPostpartum Hospital Stay (days)Vacuum-assisted delivery (62 cases)3 (3, 3)a41.722<0.001–Forceps Delivery (30 cases)3 (3, 3.25)a–Cesarean Section (22 cases)4 (4, 5)b–Hospitalization Costs (CNY)Vacuum–assisted delivery (62 cases)5955 (4540, 7625)a43.682<0.001–Forceps Delivery (30 cases)5404 (4254, 6361)a–Cesarean Section (22 cases)10491 (9514, 11666)b–Days of Antibiotic Use (days)Vacuum-assisted delivery (62 cases)0 (0, 1)a44.512<0.001–Forceps Delivery (30 cases)0 (0, 1)a–Cesarean Section (22 cases)3 (1.75, 3.25)b–Days of Catheterization (days)Vacuum–assisted delivery (62 cases)0 (0, 1)a26.963<0.001–Forceps Delivery (30 cases)0 (0, 1)a–Cesarean Section (22 cases)1 (1, 1)b–Urinary RetentionVacuum–assisted delivery (62 cases)4 (6.5%)0.1810.8871.8% - 15.8%Forceps Delivery (30 cases)2 (6.7%) 0.8% - 22.1%Cesarean Section (22 cases)2 (9.1%)1.1% - 29.2%FeverVacuum–assisted delivery (62 cases)5 (8.1%)1.6980.672.7% - 17.8%Forceps Delivery (30 cases)2 (6.7%)0.8% - 22.1%Cesarean Section (22 cases)3 (13.6%)2.9% - 34.9%Wound ErythemaVacuum–assisted delivery (62 cases)21 (33.9%)a,b6.3410.04222.4% - 46.9%Forceps Delivery (30 cases)12 (40.0%)b22.7% - 59.4%Cesarean Section (22 cases)2 (9.1%)a1.1% - 29.2%Blood Loss (mL)Vacuum–assisted delivery (62 cases)200 (150, 200)a37.587<0.001–Forceps Delivery (30 cases)180 (150, 250)a–Cesarean Section (22 cases)400 (375, 400)b–PPHVacuum–assisted delivery (62 cases)2 (3.2%)1.6980.5180.4% - 11.2%Forceps Delivery (30 cases)2 (6.7%)0.8% - 22.1%Cesarean Section (22 cases)0 (0.0%)0.0% - 15.4%Notes: Post-hoc pairwise comparisons were performed using Bonferroni correction. Within the same parameter, different letters a,bIndicate statistically significant differences between groups (P < 0.05), while parameters without letter annotations indicate no significant differences among groups. Note: For variables that are not normally distributed, we describe their central tendency and dispersion using the median and interquartile range (IQR). The calculation of confidence intervals for the median requires resampling methods, the interpretation of which is relatively complex and does not typically alter the main conclusions; therefore, they were not provided.Abbreviations: HB, Hemoglobin concentration; PPH, Postpartum Hemorrhage. Table 4Comparison of Maternal OutcomesGroupH/χ2P95% CIPostpartum Hospital Stay (days)Vacuum-assisted delivery (62 cases)3 (3, 3)a41.722<0.001–Forceps Delivery (30 cases)3 (3, 3.25)a–Cesarean Section (22 cases)4 (4, 5)b–Hospitalization Costs (CNY)Vacuum–assisted delivery (62 cases)5955 (4540, 7625)a43.682<0.001–Forceps Delivery (30 cases)5404 (4254, 6361)a–Cesarean Section (22 cases)10491 (9514, 11666)b–Days of Antibiotic Use (days)Vacuum-assisted delivery (62 cases)0 (0, 1)a44.512<0.001–Forceps Delivery (30 cases)0 (0, 1)a–Cesarean Section (22 cases)3 (1.75, 3.25)b–Days of Catheterization (days)Vacuum–assisted delivery (62 cases)0 (0, 1)a26.963<0.001–Forceps Delivery (30 cases)0 (0, 1)a–Cesarean Section (22 cases)1 (1, 1)b–Urinary RetentionVacuum–assisted delivery (62 cases)4 (6.5%)0.1810.8871.8% - 15.8%Forceps Delivery (30 cases)2 (6.7%) 0.8% - 22.1%Cesarean Section (22 cases)2 (9.1%)1.1% - 29.2%FeverVacuum–assisted delivery (62 cases)5 (8.1%)1.6980.672.7% - 17.8%Forceps Delivery (30 cases)2 (6.7%)0.8% - 22.1%Cesarean Section (22 cases)3 (13.6%)2.9% - 34.9%Wound ErythemaVacuum–assisted delivery (62 cases)21 (33.9%)a,b6.3410.04222.4% - 46.9%Forceps Delivery (30 cases)12 (40.0%)b22.7% - 59.4%Cesarean Section (22 cases)2 (9.1%)a1.1% - 29.2%Blood Loss (mL)Vacuum–assisted delivery (62 cases)200 (150, 200)a37.587<0.001–Forceps Delivery (30 cases)180 (150, 250)a–Cesarean Section (22 cases)400 (375, 400)b–PPHVacuum–assisted delivery (62 cases)2 (3.2%)1.6980.5180.4% - 11.2%Forceps Delivery (30 cases)2 (6.7%)0.8% - 22.1%Cesarean Section (22 cases)0 (0.0%)0.0% - 15.4%Notes: Post-hoc pairwise comparisons were performed using Bonferroni correction. Within the same parameter, different letters a,bIndicate statistically significant differences between groups (P < 0.05), while parameters without letter annotations indicate no significant differences among groups. Note: For variables that are not normally distributed, we describe their central tendency and dispersion using the median and interquartile range (IQR). The calculation of confidence intervals for the median requires resampling methods, the interpretation of which is relatively complex and does not typically alter the main conclusions; therefore, they were not provided.Abbreviations: HB, Hemoglobin concentration; PPH, Postpartum Hemorrhage. Comparison of Maternal Outcomes Notes: Post-hoc pairwise comparisons were performed using Bonferroni correction. Within the same parameter, different letters a,bIndicate statistically significant differences between groups (P < 0.05), while parameters without letter annotations indicate no significant differences among groups. Note: For variables that are not normally distributed, we describe their central tendency and dispersion using the median and interquartile range (IQR). The calculation of confidence intervals for the median requires resampling methods, the interpretation of which is relatively complex and does not typically alter the main conclusions; therefore, they were not provided. Abbreviations: HB, Hemoglobin concentration; PPH, Postpartum Hemorrhage. Discussion This retrospective study analyzed 114 cases of PD occurring in the second stage of labor to compare maternal and neonatal outcomes associated with three delivery methods: vacuum extraction, forceps delivery, and cesarean section. The principal findings indicate a distinct trade-off between these approaches. Cesarean section was associated with a longer interval from deceleration to delivery, significantly increased postpartum blood loss, prolonged hospitalization, and higher medical costs. However, the fewer deceleration episodes recorded in this group suggest that the decision for surgical intervention may have been made at an earlier stage of the fetal heart rate abnormality. In contrast, operative vaginal delivery (vacuum extraction and forceps) demonstrated a significant advantage in shortening the duration of potential fetal compromise and offered benefits in terms of reduced maternal trauma and faster recovery. Nonetheless, forceps delivery was linked to a higher incidence of perineal wound erythema. The lower pre-delivery hemoglobin level observed in the vacuum extraction group may indicate underlying baseline differences in this patient cohort. Collectively, these results underscore that there is no single universally optimal delivery method for managing PD in the second stage of labor. The cornerstone of clinical decision-making lies in a rapid, structured assessment: when fetal station is favorable (≥ +2) and an experienced operator is available, operative vaginal delivery should be prioritized to expedite delivery and minimize maternal morbidity; whereas cesarean section is reserved for high fetal stations (≤ +1) or when vaginal delivery is unsafe, with the understanding that it carries greater maternal morbidity.8,13,14 The choice between vacuum and forceps involves a balance of risks, with forceps posing a higher risk of maternal perineal trauma and vacuum extraction carrying a greater risk of neonatal scalp injury.15–18 Analysis of Fetal Monitoring Indicators and Baseline Characteristics Our results indicate that the interval from the onset of fetal heart rate deceleration to delivery was significantly longer in the cesarean section group compared to both the vacuum extraction and forceps groups (P<0.05). Conversely, the number of deceleration episodes recorded was significantly lower in the cesarean section group than in the two operative vaginal delivery groups (P<0.05). No significant differences were observed among the three groups in other fetal monitoring parameters, including the duration of single deceleration episodes, total deceleration time, depth of deceleration, baseline variability, or the presence of non-periodic accelerations (P>0.05). These findings suggest that different management strategies for PD in the second stage of labor have distinct time-related implications. Upon identifying PD, clinicians must promptly investigate possible causes, such as maternal circulatory compromise (eg, supine hypotension), umbilical cord prolapse, vagal reflex triggered by rapid fetal descent, uterine tachysystole, or prolonged uterine contractions.2,19 If fetal heart rate abnormalities persist despite corrective measures, especially if evolving into a prolonged deceleration lasting more than 10 minutes (which indicates terminal bradycardia),4,13 expedited delivery becomes critical. The longer interval from deceleration to delivery in the cesarean group primarily reflects the necessary time for transferring the patient to the operating room, administering anesthesia, and completing preoperative preparations. Additionally, interruptions in fetal monitoring during these processes likely contributed to the fewer recorded deceleration episodes in this group. This underscores the importance of efficient multidisciplinary collaboration and standardized protocols to minimize fetal hypoxia exposure during obstetric emergencies.20 Fetal station was a key factor influencing delivery mode selection. The significantly higher fetal station (indicating less descent) in the cesarean section group compared to the operative vaginal delivery groups (P<0.05) aligns with clinical practice, as a fetal station of ≤ +2 is generally considered unfavorable for successful instrumental delivery.14 Therefore, immediate assessment of fetal station at the occurrence of PD is crucial. Subsequent decision-making should incorporate this information along with fetal descent degree, maternal condition, labor progress, and operator experience to rapidly select the safest and most effective delivery method. Regarding baseline characteristics, the pre-delivery hemoglobin level was significantly lower in the vacuum extraction group than in the forceps and cesarean groups (P<0.05). Considering the retrospective design and the unequal group sizes (vacuum extraction, n=62; forceps, n=30; cesarean, n=22), this finding might be influenced by confounding factors. Whether pre-delivery hemoglobin levels affect the choice of delivery method during second-stage emergencies, and how they impact maternal and neonatal outcomes, warrants further investigation in larger, prospective studies. Analysis of Neonatal Outcomes The pathophysiology of PD during the second stage of labor primarily involves fetal myocardial hypoxia and the vagal reflex.21 When fetal monitoring indicates Category II or III patterns, it suggests a potential hypoxic state, which triggers a compensatory shift to anaerobic metabolism. This results in increased lactate production and accumulation. Given lactate’s neurotoxicity and the high susceptibility of brain tissue to hypoxia, the buildup of lactate significantly increases the risk of cerebral cell injury, forming a core pathological basis for severe complications such as hypoxic-ischemic encephalopathy.22 Failure to promptly correct hypoxia elevates the risks of neonatal acidosis, need for NICU admission, and birth asphyxia, which in severe cases can progress to multi-organ dysfunction or perinatal death.23 This study demonstrated no statistically significant differences among the three groups in various neonatal outcomes, including birth weight, gestational age at delivery, preterm birth rate, amniotic fluid characteristics, umbilical artery pH, incidence of acidosis (pH<7.20), lactate levels, rates of birth asphyxia, or NICU admissions (all P > 0.05). We posit that the timely recognition of PD and the subsequent expedited intervention itself—irrespective of the final route—is the most critical factor in preserving neonatal well-being. The comparable neonatal results across the three delivery modalities likely reflect a balance of their respective advantages and disadvantages, mitigated by prompt action. However, it is crucial to note that our study assessed only short-term neonatal outcomes; long-term neurodevelopmental follow-up studies are warranted to rule out more subtle differences.24,25 Instrumental vaginal delivery can enable rapid fetal expulsion, potentially reducing intrauterine hypoxia duration. Forceps-assisted delivery is particularly effective for swift completion of labor and may be associated with a lower risk of fetal scalp hematoma compared to vacuum extraction. However, its application is limited in certain fetal positions, such as occiput transverse or posterior, and improper use increases the risk of maternal soft tissue injury and neonatal facial trauma.15 Vacuum extraction is simpler to perform, can aid in fetal head rotation, and generally causes less maternal soft tissue damage but carries a higher risk of neonatal scalp injuries.16,17 Overall, vaginal instrumental delivery may be associated with neonatal complications such as skin lacerations, intracranial hemorrhage, and facial nerve palsy,18 although some long-term follow-up studies have not established a definitive link with adverse neurodevelopmental outcomes.24,25 In contrast, emergency cesarean section, while avoiding the mechanical trauma associated with passage through the birth canal, involves longer preoperative preparation, anesthesia administration, and surgical duration, which can prolong fetal hypoxia exposure. A deeply engaged fetal head poses a significant technical challenge during second-stage cesarean sections, with an incidence reaching up to 11% in emergency cases.26–28 This can lead to difficulties in fetal extraction, extension of the uterine incision, increased intraoperative hemorrhage, and neonatal injury. Although various techniques—such as reverse breech extraction or push-up maneuvers—are employed to manage impacted fetal heads, high-quality evidence supporting the superiority of any single method remains lacking.29–31 The results of this study indicate no significant differences in short-term neonatal outcomes among the three modes of delivery during PD in the second stage. This emphasizes the importance of individualized clinical decision-making. Obstetric teams should comprehensively evaluate fetal station, labor progress, fetal tolerance, maternal condition, and operator experience to select the most appropriate approach for rapid and safe delivery. The key is the accurate and timely identification of fetal heart rate abnormalities to enable swift, effective intervention, thereby maximizing maternal and neonatal safety.32 Analysis of Maternal Outcomes The results of this study demonstrate that the cesarean section group experienced significantly longer postpartum hospital stays, higher hospitalization costs, prolonged durations of antibiotic administration and indwelling catheterization, and greater postpartum blood loss compared to both the vacuum extraction and forceps groups (all P < 0.05). These findings align with existing literature, which indicates that cesarean delivery during the second stage of labor is typically associated with a longer recovery period and increased utilization of medical resources.13,33 These differences are intrinsically linked to the specific characteristics of each delivery method. Cesarean section is an abdominal surgical procedure classified as a Class II incision, generally requiring a longer operative time, urinary catheterization, and carrying a higher risk of postoperative infection—hence the routine use of prophylactic antibiotics.34 Conversely, operative vaginal deliveries usually do not necessitate routine prophylactic antibiotics,35 which explains the longer course of antibiotic use observed in the cesarean group. Additionally, prolonged fetal head pressure during the second stage can cause edema and impair contractility of the lower uterine segment. When coupled with a low fetal station, these factors can increase the difficulty of fetal extraction and the likelihood of extension of the uterine incision during cesarean section, thus elevating the risk of hemorrhage.36,37 This correlates with the higher blood loss observed in the cesarean group. Regarding soft tissue injury, the incidence of wound redness was significantly higher in the forceps group compared to the cesarean group (P < 0.05). However, this result should be interpreted cautiously due to the relatively small sample size of the forceps group (n=30) and the absence of a significant difference between the vacuum extraction and cesarean groups. Nonetheless, forceps application can potentially exacerbate trauma to edematous and pressure-affected perineal tissues, increasing local inflammatory responses. Therefore, forceps-assisted delivery should be performed with gentle techniques to prevent excessive traction, and close postoperative monitoring of the perineal wound is essential, with appropriate anti-inflammatory or antibiotic treatment if needed. From the maternal outcome perspective, this study confirms that each delivery method used during the second stage of labor carries a distinct risk profile. Cesarean section is associated with higher risks of hemorrhage, longer recovery times, and increased medical costs. While operative vaginal delivery can shorten the duration of labor, forceps assistance may elevate the risk of soft tissue trauma. These findings underscore the importance of comprehensive preoperative assessment during urgent decision-making, including evaluation of maternal baseline status, labor progression, fetal station, and potential complications, in order to select the most suitable individualized delivery strategy. Seamless teamwork, accurate risk assessment, and adherence to standardized operative techniques are key to optimizing maternal outcomes and enhancing the childbirth experience. Limitations This study has several limitations inherent to its retrospective design. The potential for selection bias and unmeasured confounding must be acknowledged, particularly regarding operator experience and preference, which significantly influenced the choice of delivery method but could not be analyzed. The small sample size, especially in the forceps and cesarean groups, limits the statistical power and generalizability of our findings. Future prospective studies are needed to validate these results. Conclusion In summary, during prolonged deceleration in the second stage of labor, the choice of delivery method presents a trade-off between maternal morbidity and procedural expediency. Our findings support a management strategy centered on rapid assessment: prioritizing operative vaginal delivery when fetal station is low and operator expertise is sufficient, and opting for cesarean section when conditions are unfavorable for vaginal birth. The consistent neonatal outcomes across all modes of delivery should reassure clinicians that, within this framework, the primary focus can be on selecting the safest and most efficient route to achieve delivery for the individual mother-baby dyad.